June 17, 2021—Cagent Vascular Inc. announced an investment of $9 million by Sectoral Asset Management, which Cagent will use to accelerate the commercialization and scaling of manufacturing for its Serranator below-the-knee (BTK) percutaneous tra…
Author: Endovascular Today - Latest News
Updated Summary-Level Analysis of Paclitaxel-Coated Devices Shows No Evidence of Increased All-Cause Mortality Risk
June 15, 2021—In an updated systematic review and meta-analysis of randomized controlled trials (RCTs) of paclitaxel-coated device (PCD) use in patients with occlusive femoropopliteal disease, Dinh et al found no increased risk of all-cause morta…
SOCRATES Study Begins in Germany to Compare ESAR and FEVAR Treatments of AAA
June 15, 2021—St. Franziskus-Hospital in Münster, Germany, announced the commencement of the postmarket SOCRATES study comparing endosuture aneurysm repair (ESAR) to fenestrated endovascular aneurysm repair (FEVAR) in patients with ho…
Neurescue’s Intelligent Balloon Catheter Cleared by FDA for Hemorrhage Control
June 10, 2021—Neurescue, a Denmark-based developer of cardiovascular solutions to improve the outcomes for emergency patients, announced that the FDA has granted 510(k) clearance to market the company’s Neurescue device for temporary occlus…
Embolx Launches Sniper in Europe
June 8, 2021—Embolx Inc., a manufacturer of microcatheters for arterial embolization procedures, announced a limited release of its Sniper balloon occlusion microcatheter in the European market.
According to the company, the Sniper delivery sy…
TripleMed’s AneuFix Device for Type II Endoleak Evaluated in Pivotal Study
June 7, 2021—TripleMed BV announced an update to enrollment in the pivotal clinical study of the company’s AneuFix device for the treatment of type II endoleaks of aortic aneurysms. AneuFix is a two-component polymer that is injected into t…
Philips’ Tack Endovascular System Shows Sustained Efficacy in 2-Year TOBA II BTK Data
June 3, 2021—Royal Philips announced results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial of the company’s Tack endovascular system (4F), a dissection repair device. In the trial, the Tack system…
Prytime Medical Closes Funding Round to Support Commercialization of Reboa Products
June 2, 2021—Prytime Medical Devices, Inc. announced the closing of a $6 million inside financing round to support commercialization of their Reboa products for resuscitative endovascular balloon occlusion of the aorta for truncal hemorrhage cont…
Avicenna.AI’s Cina Chest Triage Solution Gains CE Mark and FDA Clearance
June 2, 2021—Avicenna.AI, a France-based company focusing on medical imaging artificial intelligence (AI) technology, announced that it has received CE Mark approval in Europe and FDA 510(k) clearance in the United States for the Cina Chest AI so…
Vesalio Secures Funding to Support Its Neurovascular Product Portfolio
June 2, 2021—Vesalio announced it has secured a Class A financing round that will support the United States stroke study being conducted under an investigational device exemption (IDE). Additionally, the proceeds will be used to establish the com…